Impact of Intensive Insulin Therapy on Neuromuscular Complications and Ventilator Dependency in the Medical Intensive Care Unit
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Rationale: Critical illness polyneuropathy/myopathy causes limb and respiratory muscle weakness, prolongs mechanical ventilation, and extends hospitalization of intensive care patients. Besides controlling risk factors, no specific prevention or treatment exists. Recently, intensive insulin therapy prevented critical illness polyneuropathy in a surgical intensive care unit. Objectives: To investigate the impact of intensive insulin therapy on polyneuropathy/myopathy and treatment with prolonged mechanical ventilation in medical patients in the intensive care unit for at least 7 days. Methods: This was a prospectively planned subanalysis of a randomized controlled trial evaluating the effect of intensive insulin versus conventional therapy on morbidity and mortality in critically ill medical patients. All patients who were still in intensive care on Day 7 were screened weekly by electroneuromyography. The effect of intensive insulin therapy on critical illness polyneuropathy/myopathy and the relationship with duration of mechanical ventilation were assessed. Measurements and Main Results: Independent of risk factors, intensive insulin therapy reduced incidence of critical illness polyneuropathy/myopathy (107/212 [50.5%] to 81/208 [38.9%], p = 0.02). Treatment with prolonged (⩾ 14 d) mechanical ventilation was reduced from 99 of 212 (46.7%) to 72 of 208 (34.6%) (p = 0.01). This was statistically only partially explained by prevention of critical illness polyneuropathy/myopathy. Conclusion: In a subset of medical patients in the intensive care unit for at least 7 days, enrolled in a randomized controlled trial of intensive insulin therapy, those assigned to intensive insulin therapy had a reduced incidence of critical illness polyneuropathy/myopathy and were treated with prolonged mechanical ventilation less frequently.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GH circulant levels also decrease after 30 years of age at a rate of ∼1% per year. These conditions induce loss of muscle mass and accumulation of visceral fat in the elderly [31, 54–58].”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [58]
In the citing paper
“Significantly, high levels of circulating free fatty acids (FFA) in elderly obesity inhibit GH production and decrease plasma levels of IGF-I, associated with low muscle mass.”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [58]
Citations
Cites
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 2×
“Details of the entire patient population have been described elsewhere (22).”
BackgroundSelf-citationOne-Year Outcomes in Survivors of the Acute Respiratory Distress Syndrome
Herridge, M. S., Cheung, A. M., Tansey, C. M., Matte-Martyn, A., Diaz-Granados, N., Al-Saidi, F., Cooper, A. B., Guest, C. B., Mazer, C. D., Mehta, S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022450 · Cited by 2,334
Paresis Acquired in the Intensive Care Unit<SUBTITLE>A Prospective Multicenter Study</SUBTITLE>
De Jonghe, B. (2002) · JAMA · doi:10.1001/jama.288.22.2859 · Cited by 1,516 · cited 2×
“In two reports, however, corticosteroids were found to be an important risk factor for the development of neuromuscular disorders in patients in the ICU (11, 33).”
BackgroundGlucocorticoids and insulin resistance: old hormones, new targets
ANDREWS, R. C., & WALKER, B. R. (1999) · Clinical Science · doi:10.1042/cs0960513 · Cited by 731 · cited 1×
“Our results, however, indicated that corticosteroids, which are known to cause hyperglycemia and insulin resistance (34), may not exert deleterious effects on CIP/CIM when blood glucose levels are kept normal with insulin, and might even be protective.”
BackgroundInsulin therapy protects the central and peripheral nervous system of intensive care patients
Van den Berghe, G., Schoonheydt, K., Becx, P., Bruyninckx, F., & Wouters, P. J. (2005) · Neurology · doi:10.1212/01.wnl.0000158442.08857.fc · Cited by 642 · cited 7×
“This was accompanied by a lower incidence of prolonged mechanical ventilation (15).”
BackgroundMethodResultInfluentialSelf-citationIntensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units
Van den Berghe, G., Wilmer, A., Milants, I., Wouters, P. J., Bouckaert, B., Bruyninckx, F., Bouillon, R., & Schetz, M. (2006) · Diabetes · doi:10.2337/db06-0855 · Cited by 599
Self-citationPeripheral Nerve Function in Sepsis and Multiple Organ Failure
Witt, N. J., Zochodne, D. W., Bolton, C. F., Grand'Maison, F., Wells, G., Young, G. B., & Sibbald, W. J. (1991) · Chest · doi:10.1378/chest.99.1.176 · Cited by 577 · cited 1×
“The reported incidence of CIP in this group is 70 to 82% (1, 2).”
BackgroundHow does blood glucose control with insulin save lives in intensive care?
Van den Berghe, G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423506 · Cited by 550 · cited 2×
“inflammation, and improvement of dyslipidemia (26, 28, 29).”
BackgroundCritical illness myopathy and neuropathy
Latronico, N., Recupero, D., Candiani, A., Guarneri, B., De Maria, G., Antonini, L., Fenzi, F., Tomelleri, G., Tonin, P., & Rizzuto, N. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91074-0 · Cited by 511
Hansen, T. K., Thiel, S., Wouters, P. J., Christiansen, J. S., & Van den Berghe, G. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021478 · Cited by 499 · cited 1×
“inflammation, and improvement of dyslipidemia (26, 28, 29).”
BackgroundSelf-citation
Research works printed but not linked: 6
- 2005, Curr Opin Crit Care, 11, 381
- 1996, Muscle Nerve, 19, 516, 10.1002/(SICI)1097-4598(199604)19:4<516::AID-MUS11>3.0.CO;2-N · doi:10.1002/(sici)1097-4598(199604)19:4<516::aid-mus11>3.0.co;2-n
- 1977, Schweiz Med Wochenschr, 107, 3
- 2006, Intensive Care Med, 32, S106
- 2002, Curr Opin Crit Care, 8, 302
- 2004, J Clin Invest, 114, 1187, 10.1172/JCI23506 · doi:10.1172/jci23506 · Paper page
Cited by
Long-term complications of critical care
Desai, S. V., Law, T. J., & Needham, D. M. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181fd66e5 · Cited by 870
“Intensive insulin therapy targeting tight glucose control has reduced some electromyographic evidence of muscle abnormality (42, 43).”
BackgroundICU-Acquired Weakness and Recovery from Critical Illness
Kress, J. P., & Hall, J. B. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1209390 · Cited by 855
Clinical review: intensive care unit acquired weakness
Hermans, G., & Van den Berghe, G. (2015) · Critical Care · doi:10.1186/s13054-015-0993-7 · Cited by 792
Self-citationAcquired Weakness, Handgrip Strength, and Mortality in Critically Ill Patients
Ali, N. A., O'Brien, J. M., Hoffmann, S. P., Phillips, G., Garland, A., Finley, J. C. W., Almoosa, K., Hejal, R., Wolf, K. M., Lemeshow, S., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200712-1829oc · Cited by 779
“To prevent (16, 17) or treat (18) ICUAP, the syndrome must first be recognized.”
BackgroundVanhorebeek, I., Latronico, N., & Van den Berghe, G. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05944-4 · Cited by 717
“However, one study suggested a protective effect of corticosteroids when hyperglycemia as a side effect was avoided [49].”
Background
Metadata
- Authors
- Hermans, G., Wilmer, A., Meersseman, W., Milants, I., Wouters, P. J., Bobbaers, H., Bruyninckx, F., & Van den Berghe, G.
- Affiliations
- Universitair Ziekenhuis Leuven (BE)
- Medical Intensive Care Unit, Department of Internal Medicine
- Department of Intensive Care Medicine, and
- KU Leuven (BE)
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-03-01
- Volume
- 175
- Issue
- 5
- Pages
- 480-489
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W1987306333
- Cited by
- 368
- References
- 39
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 17 · 2023: 15 · 2022: 14 · 2021: 13 · 2020: 19 · 2019: 14 · 2018: 14 · 2017: 13 · 2016: 23 · 2015: 21 · 2014: 21 · 2013: 20 · 2012: 13
- FWCI
- 29.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Keywords
- intensive insulin therapy, critical illness polyneuropathy, critical illness myopathy, mechanical ventilation duration, ventilator dependence, neuromuscular complications, glycemic control, respiratory muscle weakness
- MeSH terms
- Blood Glucose, Critical Care, Dose-Response Relationship, Drug, Electromyography, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Insulin, Male, Middle Aged, Neuromuscular Diseases, Prospective Studies, Respiration, Artificial, Respiratory Insufficiency, Respiratory Muscles, Critical Illness, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of Intensive Insulin Therapy on Neuromuscular Complications and Ventilator Dependency in the Medical Intensive Care Unit. https://app.cochat.ai/papers/10.1164/rccm.200605-665oc
- The paper
- Hermans, G., Wilmer, A., Meersseman, W., Milants, I., Wouters, P. J., Bobbaers, H., Bruyninckx, F., & Van den Berghe, G. (2007). Impact of Intensive Insulin Therapy on Neuromuscular Complications and Ventilator Dependency in the Medical Intensive Care Unit. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.200605-665oc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.